C16 Ceramide (d18:1(D7)/16:0(13C16)) 793044 N-palmitoyl(13C16))-D-erythro-sphingosine(d18:1(D7))
Monitoring the levels of the ceramides (Cer) d18:1/16:0 and ratios thereof in human plasma empowers the prediction of fatal outcome of coronary artery disease. Avanti has now made available these ceramides in a stable isotope form as a convenience for a newly described validated liquid chromatography-tandem mass spectrometry methodology for their clinical-scaled measurement. This product is deuterated which will enable the study of structure, dynamics, and function of this lipid within the cell.
Refer: D. Kauhanen et al. (2016). Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides. Anal Bioanal Chem 408:3475-83
Refer: D. Kauhanen et al. (2016). Development and validation of a high-throughput LC-MS/MS assay for routine measurement of molecular ceramides. Anal Bioanal Chem 408:3475-83